Showing results (801-810 of 1,246) with videos related to
Sort By:
Pageof 125
Cancer Treatment and Research Communications|October 4, 2025
Correlation between TTF-1 expression and EGFR mutations in moroccan lung adenocarcinoma: A prospective six-year studySara Boukansa, Ismail Mouhrach, Fatima El Agy, et al.Cancer Treatment and Research Communications|September 11, 2025
Rationale and design of the PAMSARC (pasireotide as maintenance treatment with monthly deep intramuscular injection in SSTR2/3/5-expressing synovial sarcoma and desmoplastic small round cell tumor) multicenter phase 2 trialChristoph E Heilig, Christoph Heining, Editha Gnutzmann, et al.Cancer Treatment and Research Communications|August 13, 2025
Real-world progression-free survival of first line afatinib patients with EGFR-mutant advanced lung adenocarcinoma: A multicentre study in IndonesiaNoni Novisari Soeroso, Elisna Syahruddin, Chaliza Soliha, et al.Cancer Treatment and Research Communications|February 12, 2026
Treatment of ER-positive breast cancer with FDA-approved aromatase inhibitorsNayoung Kim, Kiven Erique LukongCancer Treatment and Research Communications|February 12, 2026
Treatment and outcomes of patients with HR+/HER2- early breast cancer in a real-world setting in GermanyKlaus-Ulrich Däßler, Volker Petersen, Mark-Oliver Zahn, et al.Cancer Treatment and Research Communications|January 29, 2026
Synergistic regulation of tumor angiogenesis via flavonoid modulation of lncRNAs: Mechanistic insights and therapeutic potentialAkanksha Gupta, G S N Koteswara Rao, Hardeep Singh Tuli, et al.Cancer Treatment and Research Communications|February 17, 2026
Impact of the COVID-19 pandemic on cancer screening in Europe: A systematic review of disruptions, barriers, and policy responsesZeyu Wang, Bohua Ren, Salman Rawaf, et al.Cancer Treatment and Research Communications|February 4, 2026
LINC01913 and LINC01389 as the novel diagnostic tumor markers for the early-stage renal cell carcinomaAmirhosein Maharati, Fatemeh Taghavinia, Alireza Golshan, et al.Cancer Treatment and Research Communications|February 13, 2026
Long-term results of postoperative whole-breast irradiation plus simultaneous integrated boost (SIB) for adolescents and young adults (AYA) diagnosed with early breast cancer after undergoing breast-conserving surgery in a single instituteYi-Ting Hwang, Hui-Ling YehCancer Treatment and Research Communications|August 1, 2025
First-line durvalumab plus platinum-etoposide in Japanese patients with extensive-stage small-cell lung cancerEisuke Mochizuki, Shun Matsuura, Naoki Koshimizu, et al.Pageof 125